This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Nov 2;142(18):1504-1506.

doi: 10.1182/blood.2023021817.

Toward rational therapy for mantle cell lymphoma

Mark A Murakami¹

Affiliations

PMID: 37917082
DOI: 10.1182/blood.2023021817

Free article

Editorial

Toward rational therapy for mantle cell lymphoma

Mark A Murakami. Blood. 2023.

Free article

. 2023 Nov 2;142(18):1504-1506.

doi: 10.1182/blood.2023021817.

Author

Mark A Murakami¹

Affiliation

¹ Dana-Farber Cancer Institute.

PMID: 37917082
DOI: 10.1182/blood.2023021817

No abstract available

PubMed Disclaimer

Comment on

CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Decombis S, Bellanger C, Le Bris Y, Madiot C, Jardine J, Santos JC, Boulet D, Dousset C, Menard A, Kervoelen C, Douillard E, Moreau P, Minvielle S, Moreau-Aubry A, Tessoulin B, Roue G, Bidère N, Le Gouill S, Pellat-Deceunynck C, Chiron D. Decombis S, et al. Blood. 2023 Nov 2;142(18):1543-1555. doi: 10.1182/blood.2023020211. Blood. 2023. PMID: 37562004

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems